上集講述了PD1/PDL1在醫治癌細胞免疫治療方面的重要性,接下來我們將會繼續深入探討問題。1156Please respect copyright.PENANA8Etouirrkw
1156Please respect copyright.PENANAf4axIaqxYn
上集:https://www.penana.com/article/4711251156Please respect copyright.PENANAYe86HJJnsI
1156Please respect copyright.PENANARtz1WQyrdP
1156Please respect copyright.PENANAxsgTPFPoDo
1156Please respect copyright.PENANAFZdZoD9Yid
(圖1)雖然阻擋PD1/PDL1可以增強T cell辨認癌細胞的能力,但另一個重要的問題是,如何確保有足夠的T cell殺滅癌細胞呢?1156Please respect copyright.PENANAjLC9DrpxAF
1156Please respect copyright.PENANAyJjRH7Sbpy
就算成功糾正免疫系統細胞懂得把癌細胞辨認為外來之物,但免疫系統細胞數量不足的話,依然是不會達到重大效果的。1156Please respect copyright.PENANA6BjG2vubIe
1156Please respect copyright.PENANAhAjaZnhjgG
換句話說,我們需要一道能夠提升針對癌細胞的T cell數量手段。1156Please respect copyright.PENANAfjmkkDSuEJ
1156Please respect copyright.PENANAPFggLlJIMp
1156Please respect copyright.PENANAL9uT7ciVLH
1156Please respect copyright.PENANAaP5rzRFDey
(圖2)T cell的產生數量,接近可以說是由Antigen Presenting Cells(APC)來決定;1156Please respect copyright.PENANAw9iWzrAyqv
APC可以睇成為一堆負責把癌細胞獨特Neoantigen帶來T cell面前的細胞。1156Please respect copyright.PENANAIddYh75YoT
1156Please respect copyright.PENANA0qpWQ3N7Sj
忘記甚麼是Neoantigen的話,可重溫上一集。1156Please respect copyright.PENANAvx6Pu9wjo8
1156Please respect copyright.PENANAgTwGPCkoG1
當APC展示癌細胞的Neoantigen予T cell的receptor後,另一個必需的動作就是T cell表面的CD28與APC表面的B7合併。1156Please respect copyright.PENANAELKeHB2o5j
1156Please respect copyright.PENANAvl9A9xABGb
只要兩者條件達成的話,負責對付對應癌細胞的T cell數量及效力便會大增。1156Please respect copyright.PENANAyq5vaqrtvz
1156Please respect copyright.PENANAW8NKGJeRNd
1156Please respect copyright.PENANAUKRb7dk4A8
1156Please respect copyright.PENANADuB53VdUTg
(圖3)然而,當T cell數量產生至一定程度的時候,T cell便會產生出CTLA4。CTLA4會搶奪CD28的位置,與B7合併。1156Please respect copyright.PENANAL8qx6EF9QZ
1156Please respect copyright.PENANALElsYFaBiS
而當CTLA4與B7合併後,T cell所產生的數量及威力就會大減。1156Please respect copyright.PENANAKM3CB9ipyS
1156Please respect copyright.PENANALREnrfPwQh
這個CTLA4產生的機制是與生俱來的,目的就是為了避免產生過量的T cell,以免身體會產生不良反應。1156Please respect copyright.PENANAH9dJtw69AH
1156Please respect copyright.PENANARTLw1KjcXN
1156Please respect copyright.PENANABvRku6oQKv
(圖4)只不過的是,現時癌細胞大敵當前,燃眉之急就是要調動大量的T cell前往討伐癌細胞。1156Please respect copyright.PENANA4HiN28WQyv
1156Please respect copyright.PENANAhiyYXKk9Fo
為此,我們重施應對PD1/PDL1故技,利用抗體阻擋CTLA4,確保CD28及B7持續合併,不斷產生效力高強的T cell。1156Please respect copyright.PENANAt3hHCAmw0S
1156Please respect copyright.PENANAtAtEk91edH
1156Please respect copyright.PENANAamF1GDCLSZ
(圖5)簡略的總結來說,為了確保有足夠的T cell消滅癌細胞,我們不惜採用阻擋CTLA4的抗體,號令身體持續產生效力高強的T cell。1156Please respect copyright.PENANAzWAsZEvWUQ
而另一邊廂,我們亦同時利用阻擋PD1/PDL1的抗體,確保T cell能夠順利把癌細胞辨認成為外來物,將其制裁。1156Please respect copyright.PENANAcwuuiJ1XKJ
1156Please respect copyright.PENANA2EHZFRnW6y
這CTLA4抗體及PD1/PDL1抗體的雙管齊下療法,將能大大提升免疫治療的效率。1156Please respect copyright.PENANA8L3Jrpgjwu
1156Please respect copyright.PENANA0CxyLTGl67
但是,並不是所有病人也能依靠這方法而得益,原因是T cell沒法能夠順利抵達癌細胞的位置以及滲入癌細胞的內部作有效的消滅。1156Please respect copyright.PENANAqpbTvbAuRU
1156Please respect copyright.PENANACIpdh1u2FG
這一方面,我們將會在下一篇免疫治療的最終章再作探討。1156Please respect copyright.PENANAbR8EP3j7ZU
1156Please respect copyright.PENANACBy1PqSnxC
1156Please respect copyright.PENANA38xS7X7CUQ
如果想我快啲出文的話,請入去Penana網站科普專欄–薯不揀單俾一個like以及Bookmark,這對我非常之重要。1156Please respect copyright.PENANArN4MdPHpm7
1156Please respect copyright.PENANAaabs4E2i7i
Link: https://www.penana.com/story/66244/%E7%A7%91%E6%99%AE%E5%B0%88%E6%AC%84-%E8%96%AF%E4%B8%8D%E6%8F%80%E5%96%AE/toc1156Please respect copyright.PENANAEGEXI6Ug8t
1156Please respect copyright.PENANAesNeI00CXp
同時亦可以在Penana網站裡按「買一嚿/半嚿薯仔」,以課金的方式推動我繼續搜羅資料寫文,多謝。1156Please respect copyright.PENANA6HusphmslV
1156Please respect copyright.PENANAgs7sIrDLwl
Link:1156Please respect copyright.PENANATIkHrqo8r1
https://www.penana.com/user/27349/%E8%96%AF%E4%BB%94%E8%81%9E%E8%8C%B1%E8%8E%89/portfolio1156Please respect copyright.PENANAiQCklq0TAK
1156Please respect copyright.PENANA5D7By8WU9K
1156Please respect copyright.PENANAzI41gyLZS2
有興趣接收科普資訊的話,歡迎follow IG: potatopigtongue。1156Please respect copyright.PENANAYUOXbjIGbu